Pharmacological chaperones: A new twist on receptor folding

Trends in Pharmacological Sciences

Volumn 21, Issue 12, 2000, Pages 466-469

  Morello, Jean Pierre ^a   Bouvier, Michel ^a   Petäjä Repo, Ulla E ^b   Bichet, Daniel G ^c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF OULU   (Finland)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE;

GENE MUTATION; GENETIC DISORDER; HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SYNTHESIS; QUALITY CONTROL; REVIEW;

EID: 0034421921     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01575-3     Document Type: Note

References (25)

1. Setting the standards: Quality control in the secretory pathway
2. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones
3. Mechanisms of protein stabilization by glycerol: Preferential hydration in glycerol-water mixtures
4. Efficient in vitro folding of the three-disulfide derivatives of hen lysozyme in the presence of glycerol
5. Microtubule assembly in the absence of added nucleotides
6. Biosynthesis and degradation of the CFTR
7. Identification of the cystic fibrosis gene: Genetic analysis
8. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation
9. Chloride conductance expressed by DF508 and other mutant CFTRs in Xenopus oocytes
10. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
11. Chemical chaperones correct the mutant phenotype of the DF508 cystic fibrosis transmembrane conductance regulator protein
12. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
13. α1-Antitrypsin deficiency
14. Conformational disease
15. Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiency
16. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones
17. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulars
18. 2 receptor antagonist
19. 2 vasopressin receptors
20. 2 receptors
21. Accelerated transport and maturation of lysosomal a-galactosidase A in Fabry lymphoblasts by enzyme inhibitor
22. α-Galactosidase A deficiency in Fabry disease
23. Aggregation of the inactive form of human a-galactosidase in the endoplasmic reticulum
24. Pharmacological rescue of mutant p53 conformation and function
25. Influence of molecular and chemical chaperones on protein folding